JD Health adds 18.44 million shares to pending-cancel list; latest HK$18.25 million buyback executed at up to HK$36.62

Bulletin Express06-16

JD Health International Inc. disclosed on 16 June 2026 that it has continued to execute its share-repurchase programme, lifting the total number of shares bought for cancellation but not yet cancelled to 18.44 million since 15 May 2026. The aggregate volume equals 0.58 % of the company’s issued share capital at the time the buyback mandate was approved.

The most recent transaction, completed on 16 June, involved 0.50 million shares repurchased on the Hong Kong Stock Exchange at prices between HK$36.18 and HK$36.62, for a total consideration of HK$18.25 million.

Despite the ongoing buybacks, JD Health’s issued share capital remained unchanged at 3.21 billion shares as of the close on 16 June 2026; all repurchased shares are awaiting formal cancellation.

Under the mandate granted on 20 June 2025, the company is authorised to repurchase up to 320.01 million shares. Following the 18.44 million shares already repurchased, capacity for a further 301.57 million shares remains.

JD Health is subject to a 30-day moratorium on issuing new shares or selling any treasury shares, extending through 16 July 2026, in line with Main Board Rule 10.06(3)(a).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101116212?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 19:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101116212","market":"hk","top_or_hot":-1,"title":"JD Health adds 18.44 million shares to pending-cancel list; latest HK$18.25 million buyback executed at up to HK$36.62","media":"Bulletin Express","content":"<p>JD Health International Inc. disclosed on 16 June 2026 that it has continued to execute its share-repurchase programme, lifting the total number of shares bought for cancellation but not yet cancelled to 18.44 million since 15 May 2026. The aggregate volume equals 0.58 % of the company’s issued share capital at the time the buyback mandate was approved.</p>\n<p>The most recent transaction, completed on 16 June, involved 0.50 million shares repurchased on the Hong Kong Stock Exchange at prices between HK$36.18 and HK$36.62, for a total consideration of HK$18.25 million.</p>\n<p>Despite the ongoing buybacks, JD Health’s issued share capital remained unchanged at 3.21 billion shares as of the close on 16 June 2026; all repurchased shares are awaiting formal cancellation.</p>\n<p>Under the mandate granted on 20 June 2025, the company is authorised to repurchase up to 320.01 million shares. Following the 18.44 million shares already repurchased, capacity for a further 301.57 million shares remains.</p>\n<p>JD Health is subject to a 30-day moratorium on issuing new shares or selling any treasury shares, extending through 16 July 2026, in line with Main Board Rule 10.06(3)(a).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health adds 18.44 million shares to pending-cancel list; latest HK$18.25 million buyback executed at up to HK$36.62</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health adds 18.44 million shares to pending-cancel list; latest HK$18.25 million buyback executed at up to HK$36.62\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-16 19:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health International Inc. disclosed on 16 June 2026 that it has continued to execute its share-repurchase programme, lifting the total number of shares bought for cancellation but not yet cancelled to 18.44 million since 15 May 2026. The aggregate volume equals 0.58 % of the company’s issued share capital at the time the buyback mandate was approved.</p>\n<p>The most recent transaction, completed on 16 June, involved 0.50 million shares repurchased on the Hong Kong Stock Exchange at prices between HK$36.18 and HK$36.62, for a total consideration of HK$18.25 million.</p>\n<p>Despite the ongoing buybacks, JD Health’s issued share capital remained unchanged at 3.21 billion shares as of the close on 16 June 2026; all repurchased shares are awaiting formal cancellation.</p>\n<p>Under the mandate granted on 20 June 2025, the company is authorised to repurchase up to 320.01 million shares. Following the 18.44 million shares already repurchased, capacity for a further 301.57 million shares remains.</p>\n<p>JD Health is subject to a 30-day moratorium on issuing new shares or selling any treasury shares, extending through 16 July 2026, in line with Main Board Rule 10.06(3)(a).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1101116212","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101116212","pubTimestamp":1781610470,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health International Inc. disclosed on 16 June 2026 that it has continued to execute its share-repurchase programme, lifting the total number of shares bought for cancellation but not yet...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康新增1844万股待注销名单；最新1,825万港元回购以最高36.62港元执行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health International Inc. disclosed on 16 June 2026 that it has continued to execute its share-repurchase programme, lifting the total number of shares bought for cancellation but not yet cancelled to 18.44 million since 15 May 2026. The aggregate volume equals 0.58 % of the company’s issued share capital at the time the buyback mandate was approved.\nThe most recent transaction, completed on 16 June, involved 0.50 million shares repurchased on the Hong Kong Stock Exchange at prices between HK$36.18 and HK$36.62, for a total consideration of HK$18.25 million.\nDespite the ongoing buybacks, JD Health’s issued share capital remained unchanged at 3.21 billion shares as of the close on 16 June 2026; all repurchased shares are awaiting formal cancellation.\nUnder the mandate granted on 20 June 2025, the company is authorised to repurchase up to 320.01 million shares. Following the 18.44 million shares already repurchased, capacity for a further 301.57 million shares remains.\nJD Health is subject to a 30-day moratorium on issuing new shares or selling any treasury shares, extending through 16 July 2026, in line with Main Board Rule 10.06(3)(a).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101116212","isCrawlerRequest":true}